Structure base drug discovery company
Amura Holdings Ltd., Minerva Building, Babraham Research Campus, Babraham, CB22 3AT, U.K.
Home
Company
Technologies
Programmes
News
Contact
Sitemap
Search
 
 
     
 

Welcome to Amura

Amura is a company dedicated to the invention of new technologies, innovative medicines and novel products for improving health.

Amura’s therapeutic focus is in the areas of osteoporosis, osteoarthritis, bone metastasis, autoimmunity (e.g. rheumatoid arthritis, psoriasis, etc.), chronic neuropathic pain and malaria.

Amura's AMcore™ scaffold is the premier chemical solutions to cysteine peptidase inhibitor design; providing Amura with significant competitive advantage for commercially attractive therapeutic indications.

Amura will leverage its resources and capabilities to secure strategic alliances with globally-recognised licensing partners thereby generating shareholder value.

 

 
Email: amura@amura.co.uk
Phone: +44(0)1223 839797 Fax: +44(0)1223 839898 Copyright © 2009 Amura Holdings Ltd.
Powered by www.dotscoms.co.uk